ProfileGDS5678 / 1432052_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 22% 22% 22% 21% 22% 21% 22% 21% 22% 22% 22% 22% 21% 22% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.5362822
GSM967853U87-EV human glioblastoma xenograft - Control 22.5131222
GSM967854U87-EV human glioblastoma xenograft - Control 32.5147422
GSM967855U87-EV human glioblastoma xenograft - Control 42.4573421
GSM967856U87-EV human glioblastoma xenograft - Control 52.4638322
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.5576121
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.5414222
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.4856921
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.4900322
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.4987322
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.4971222
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.4913622
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.5046321
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.5006322